Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.2:1
Daily Buy & Sell Volume
Transactions (1069)
INSMED Inc (INSM)
Lewis William — Director
Shares
6,515
Price
$94.03
Total Value
$612.61K
Shares Held After
258,917
% of Holdings
2.5%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
1,120
Price
$271.14
Total Value
$303.68K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
OYLER JOHN — Director
Shares
3,820
Price
$270.38
Total Value
$1.03M
Shares Held After
1,120
% of Holdings
77.3%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
36
Price
$272.08
Total Value
$9.79K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Ball Titus B. — Principal Accounting Officer
Shares
100
Price
$271.06
Total Value
$27.11K
Shares Held After
36
% of Holdings
73.5%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
40
Price
$270.55
Total Value
$10.82K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wu Xiaobin — President and COO
Shares
1,444
Price
$269.33
Total Value
$388.92K
Shares Held After
40
% of Holdings
97.3%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
160
Price
$271.26
Total Value
$43.40K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Lee Chan Henry — SVP, General Counsel
Shares
711
Price
$270.24
Total Value
$192.14K
Shares Held After
160
% of Holdings
81.6%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
40
Price
$270.73
Total Value
$10.83K
Shares Held After
0
% of Holdings
100.0%
BeOne Medicines Ltd. (ONC)
Wang Lai — President, Global Head of R&D
Shares
1,327
Price
$269.34
Total Value
$357.42K
Shares Held After
40
% of Holdings
97.1%
Liquidia Corp (LQDA)
Khindri Sanjeev — Chief Development Officer
Shares
4,134
Price
$65.46
Total Value
$270.61K
Shares Held After
67,132
% of Holdings
5.8%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
2,804
Price
$66.19
Total Value
$185.59K
Shares Held After
1,636,941
% of Holdings
0.2%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
39,187
Price
$65.38
Total Value
$2.56M
Shares Held After
1,639,745
% of Holdings
2.3%
Liquidia Corp (LQDA)
Bloch Stephen M — Director
Shares
106,310
Price
$64.49
Total Value
$6.86M
Shares Held After
1,678,932
% of Holdings
6.0%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
3,036
Price
$89.63
Total Value
$272.12K
Shares Held After
324,879
% of Holdings
0.9%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
14,469
Price
$88.79
Total Value
$1.28M
Shares Held After
327,915
% of Holdings
4.2%
Nuvalent, Inc. (NUVL)
Porter James Richard — Director
Shares
12,495
Price
$87.97
Total Value
$1.10M
Shares Held After
342,384
% of Holdings
3.5%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,567
Price
$95.12
Total Value
$149.05K
Shares Held After
44,788
% of Holdings
3.4%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,175
Price
$93.95
Total Value
$110.39K
Shares Held After
46,355
% of Holdings
2.5%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
2,258
Price
$92.84
Total Value
$209.63K
Shares Held After
47,530
% of Holdings
4.5%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
24,428
Price
$5.43
Total Value
$132.63K
Shares Held After
1,405,995
% of Holdings
1.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
4,170
Price
$5.43
Total Value
$22.64K
Shares Held After
308,901
% of Holdings
1.3%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
10,271
Price
$5.43
Total Value
$55.77K
Shares Held After
557,504
% of Holdings
1.8%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
4,826
Price
$5.43
Total Value
$26.20K
Shares Held After
446,308
% of Holdings
1.1%
FRACTYL HEALTH, INC. (GUTS)
Smith Weber Lara — Chief Financial Officer
Shares
20,000
Price
$0.69
Total Value
$13.71K
Shares Held After
20,000
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$551.75
Total Value
$44.14K
Shares Held After
18,876
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
610
Price
$551.28
Total Value
$336.28K
Shares Held After
18,956
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,285
Price
$550.09
Total Value
$706.87K
Shares Held After
19,566
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
425
Price
$549.38
Total Value
$233.49K
Shares Held After
20,851
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,158
Price
$547.91
Total Value
$1.18M
Shares Held After
21,276
% of Holdings
9.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,888
Price
$547.03
Total Value
$1.03M
Shares Held After
23,434
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,989
Price
$546.13
Total Value
$1.09M
Shares Held After
25,322
% of Holdings
7.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,565
Price
$544.93
Total Value
$852.82K
Shares Held After
27,311
% of Holdings
5.4%
Tonix Pharmaceuticals Holding Corp. (TNXP)
Stillwell Richard Newcomb — Director
Shares
5,000
Price
$11.65
Total Value
$58.25K
Shares Held After
5,000
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$16.94
Total Value
$33.88K
Shares Held After
24,500
% of Holdings
8.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$551.37
Total Value
$352.88K
Shares Held After
40,513
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$550.40
Total Value
$357.76K
Shares Held After
41,153
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
948
Price
$549.58
Total Value
$521.01K
Shares Held After
41,803
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,144
Price
$547.93
Total Value
$1.17M
Shares Held After
42,751
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.07
Total Value
$834.28K
Shares Held After
44,895
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,131
Price
$546.13
Total Value
$1.16M
Shares Held After
46,420
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,462
Price
$544.89
Total Value
$796.63K
Shares Held After
48,551
% of Holdings
2.9%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
524
Price
$2.11
Total Value
$1.11K
Shares Held After
514,903
% of Holdings
0.1%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
249
Price
$2.11
Total Value
$525.64
Shares Held After
506,748
% of Holdings
0.0%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
5,222
Price
$27.30
Total Value
$142.56K
Shares Held After
139,763
% of Holdings
3.6%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
60,547
Price
$0.40
Total Value
$24.22K
Shares Held After
377,211
% of Holdings
13.8%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
5,045
Price
$1.57
Total Value
$7.92K
Shares Held After
69,553
% of Holdings
7.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
49,966
Price
$1.57
Total Value
$78.45K
Shares Held After
688,926
% of Holdings
7.3%
Metagenomi Therapeutics, Inc. (MGX)
Wapnick Pamela — Chief Financial Officer
Shares
2,884
Price
$1.30
Total Value
$3.75K
Shares Held After
208,491
% of Holdings
1.4%
Showing 151–200 of 1069 transactions (page 4 of 22)